Form D · Biotechnology
VuEssence, Inc.
Odessa, FL · CIK 0001675398
Offering snapshot reported May 12, 2025 · SEC filing
- Reported sold
- $47.5K Offering amount: $250K
- Investors reported
- 3 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Apr 25, 2025 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| May 12, 2025 | Initial | $47,500 | No comparison | 3 | SEC filing |
| Jan 14, 2020 | Initial | $1,050,000 | No comparison | 1 | SEC filing |
| Apr 4, 2018 | Initial | $1,500,000 | No comparison | 3 | SEC filing |
| May 25, 2016 | Initial | $1,200,000 | No comparison | 1 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-545737
Source: Form D, filed May 12, 2025. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Jeffrey Barnes | Director |
| Virginia Cates | Director |
| Maha Sallam | Director, Executive, Promoter |
| Lorne Thomas | Director |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
17633 Gunn Highway Ste 107
Odessa, FL, 33556
Odessa, FL, 33556